NASDAQ
Inhibrx Biosciences, Inc. (INBX) has a price/sales ratio of 941.13x as of Friday, May 22, 2026. This represents a 34.76% increase compared to its 12-month average of 698.36x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.